ArticleThe Journal of antibiotics2021

In vitro and in vivo activity of GT-1, a novel siderophore cephalosporin, and GT-055, a broad-spectrum β-lactamase inhibitor, against biothreat and ESKAPE pathogens.

Stephanie A Halasohoris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.